Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Scandic in connection with its repurchase of convertible bonds
Mandate

Vinge has advised Scandic in connection with its repurchase of convertible bonds

November 20, 2023 Banking and Finance Capital Markets and Public M&A

Vinge has advised Scandic Hotels Group AB (publ) (”Scandic”) in connection with its repurchase of convertible bonds.

In total, convertible bonds with an aggregate nominal amount of SEK 590.2 million were repurchased through an modified Dutch auction procedure.

Scandic is the largest hotel company in the Nordic countries with a network of about 280 hotels with 58,000 rooms in operation and under development, in more than 130 destinations. Scandic is listed on Nasdaq Stockholm.

Vinge’s team has consisted of Jesper Schönbeck, Amanda Knutsson, William Kåge, Lovisa Jonassen (Capital markets and public M&A), Louise Brorsson Salomon and Arvid Weimers (Banking and finance)

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026